Abstract:BACKGROUND: Due to the lack of autograft transplant rejection, Schwann cells (SCs) can promote the proliferation of embryonic stem cells and the induction of dopaminergic neurons. Mesencephalic stem cells can be induced to produce dopaminergic neurons. The therapeutic effects of co-grafts of SCs and neural stein cells (NSCs) deserves further study and verification in Parkinsonian animal models.OBJECTIVE: To investigate the effects of Schwann cells and mesencephalic NSC co-grafts in Parkinsonian animal models on animal behavior and histology. DESIGN: Randomized controlled experiment. SETTING: Fudan University; Institute of Neuroscience, Chinese Academy of Sciences.MATERIALS: The following animals were obtained from the Experimental Animal Center, Shanghai Institute for Biological Science, Chinese Academy of Sciences: 5 Sprague-Dawley rats, embryonic clay (E) 13-16; 16 neonatal Sprague-Dawley rats, postnatal day 1-3; and 18 adult SD rats of both genders. Animal experimentation met animal ethical approval.METHODS: ne experiment was performed at the Department of Anatomy, Histology and Embryology, Shanghai Medical Center, Fudan University from September 2005 to January 2007. The mesencephalic NSCs were obtained from the brains of SD rats at E 13-16, and SCs were harvested from the sciatic nerves of neonatal rats at day 1-3. Hemiparkinsonian rats (n =18) were selected for transplantation after estimating rotational behavior in response to apomorphine and were randomly assigned to three groups: control group, NSC group, and co-graft group. There were 6 rats in each group. Either phosphate buffered saline (PBS), NSCs. or SCs plus NSCs were transplanted into the right neostriatum of Parkinsonian rats, respectivelyMAIN OUTCOME MEASURES: (1) Rotational behavior was induced by apomorphine (0.05 mg/kg, i.p.) 2, 4, 6, 8, and 10 weeks after transplantation, and the number of rotations were counted. (2) Differentiation and survival of dopaminergic neurons in the right neostriatum were quantified by tyrosine hydroxylase immunohistochemistry 10 weeks after grafting.RESULTS: All 18 Parkinsonian rats were included in the final analysis,without any loss. (1) Rotation behavior and turning: Compared with the control group, the percent of apomorphine-induced rotations were significantly decreased (P < 0.01) in both the NSC group and co-graft group. (2) Differentiation and survival of dopaminergic neurons in each group: TH-immunoreactive neurons were detected in the striatum of both the NSC group and co-graft group 10 weeks after transplantation. The neuronal volume, size of the nucleus, and neuronal numbers were larger in the co-graft group compared to the NSC group (P < 0.05).CONCLUSION: SC and NSC co-grafts not only improve Parkinsonian behavior in rats, but also improve the survival of NSCs.

Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats

Fetal Intra-Nigral Ventral Mesencephalon and Kidney Tissue Bridge Transplantation Restores the Nigrostriatal Dopamine Pathway in Hemi-Parkinsonian Rats

Bridging Nigrostriatal Pathway with Fibroblast Growth Factor-Primed Peripheral Nerves and Fetal Ventral Mesencephalon Transplant Recuperates from Deficits in Parkinsonian Rats

Long-term Restoration of Nigrostriatal System Function by Implanting GDNF Genetically Modified Fibroblasts in a Rat Model of Parkinson’s Disease

Effect of Intranigral Injection of GDNF and EGF on the Survival and Possible Differentiation Fate of Progenitors and Immature Neurons in 6-Ohda-lesioned Rats

Constructing a New Nigrostriatal Pathway in the Parkinsonian Model with Bridged Neural Transplantation in Substantia Nigra

Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.

Co-Transplantation of Gdnf-Overexpressing Neural Stem Cells and Fetal Dopaminergic Neurons Mitigates Motor Symptoms in A Rat Model of Parkinson'S Disease

Non-dopaminergic neurons in ventral mesencephalic transplants make widespread axonal connections in the host brain

Connectivities of the striatal grafts in adult rat brain: a rich afference and scant striatonigral efference

Modulating Microglia/Macrophage Activation by CDNF Promotes Transplantation of Fetal Ventral Mesencephalic Graft Survival and Function in a Hemiparkinsonian Rat Model

Striatal grafts in rats with unilateral neostriatal lesions—II. In vivo monitoring of gaba release in globus pallidus and substantia nigra

Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism

Long-Term Therapeutic Effects on Parkinsonian Rats of Intrastriatal Co-Grafts with Genetically Engineered Fibroblasts Expressing Tyrosine Hydroxylase and Glial Cell Line-Derived Neurotrophic Factor

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor

Neural Transplantation and Trophic Factors in Parkinson's Disease: Special Reference to Chromaffin Cell Grafting, NGF Support from Pretransected Peripheral Nerve, and Encapsulated Dopamine-Secreting Cell Grafting

Dopamine Cell Therapy: From Cell Replacement to Circuitry Repair

Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in Parkinsonian rats

Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats

Improvement of Parkinsonian Behavior with Co-Grafts of Schwann Cells and Neural Stem Cells in the Rat

Delayed Gene Therapy of Glial Cell Line-Derived Neurotrophic Factor is Efficacious in a Rat Model of Parkinson's Disease.